直近一年間の累計
アクセス数 : ?
ダウンロード数 : ?
ID 115897
著者
Danne, Thomas Hannover Medical School
Sussebach, Christian Sanofi
Goyeau, Harmonie Sanofi
Lauand, Felipe Sanofi
Niemoeller, Elisabeth Sanofi
Bolli, Geremia B. Perugia University
キーワード
basal insulin
glycaemic control
hypoglycaemia
insulin analogues
meta-analysis
type 1 diabetes
資料タイプ
学術雑誌論文
抄録
Severe hypoglycaemia (SH) remains a challenge to people with type 1 diabetes (T1DM), and new‐generation basal insulins may improve patient outcomes. This post hoc meta‐analysis explored the risk of SH with insulin glargine 300 U/mL (Gla‐300) versus glargine 100 U/mL (Gla‐100) in a pooled population with T1DM from three randomized, multicentre, 6‐month similarly designed phase 3 trials: EDITION 4, EDITION JP 1 and EDITION JUNIOR. Endpoints included incidence and time to first occurrence of SH. Among 629 and 626 participants randomized to Gla‐300 and Gla‐100, respectively, glycated haemoglobin reductions were similar. Fewer participants experienced ≥1 SH event with Gla‐300 (6.2%) than with Gla‐100 (9.3%). From baseline to month 6, the risk of a first SH event was lower with Gla‐300: hazard ratio 0.65 [95% confidence interval (CI) 0.44–0.98; stratified log‐rank test P = 0.038]. SH event rates were numerically lower with Gla‐300 versus Gla‐100 from baseline to month 6 [relative risk (RR) 0.80 (95% CI 0.49–1.29); P = 0.356] and baseline to week 8 [RR 0.73 (95% CI 0.37–1.44); P = 0.369]. Thus, Gla‐300 demonstrated similar glycaemic control with lower risk of SH versus Gla‐100, particularly during the titration period.
掲載誌名
Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics
ISSN
14631326
cat書誌ID
AA11435496
出版者
John Wiley & Sons
22
10
開始ページ
1880
終了ページ
1885
発行日
2020-06-09
権利情報
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License(https://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
EDB ID
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
先端酵素学研究所